In the early 2010s, complete remission with anti-CD19 CAR T cell therapy was reported in patients with chronic lymphoblastic leukemia (CLL) and acute lymphoblastic leukemia (ALL) [10,11]. Here, CD19 is linked to acute lymphoblastic leukemia.